about
Neuroprotection for ischemic stroke: past, present and futureImproved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetamPiracetam in severe breath holding spellsMicrostates in resting-state EEG: current status and future directions.The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptideEffect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery: A meta-analysis.Piracetam improves mitochondrial dysfunction following oxidative stress.Cannabis-induced impairment of learning and memory: effect of different nootropic drugsBiological approaches to aphasia treatment.Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function.Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease.An Update on Medications and Noninvasive Brain Stimulation to Augment Language Rehabilitation in Post-Stroke Aphasia.Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam.Development and validation of spectrophotometric methods for simultaneous estimation of citicoline and piracetam in tablet dosage form.Piracetam-induced changes on the brainstem auditory response in anesthetized juvenile rhesus monkeys (Macaca mulatta). Report of two clinical cases.Effect of piracetam and vitamin E on phosphamidon-induced impairment of memory and oxidative stress in rats.The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and ratsOxidative Stress in a Model of Toxic Demyelination in Rat Brain: The Effect of Piracetam and Vinpocetine
P2860
Q24645185-D4CF48CA-3396-4F8D-AACB-C332DDE49135Q27500402-756072B0-4C6B-4944-8BA5-2564C1909CFEQ28291744-AED35879-B174-4BC2-B3E7-95251FC3BA1EQ30392511-824546EE-D2FA-4B40-88C0-D115557A68F4Q33870388-B76FACE5-0D68-4E06-940A-E5EFC3F1314AQ35084302-7B54875B-E834-4E24-B6EF-26758EE4D25CQ35098643-35E3A8F8-B94B-482D-8053-5531A23ED1D8Q36003195-A0AD4E13-B0E7-4923-9C15-FF2FDEF64B73Q36119109-8708B944-121F-4A2B-8BB8-3BB181C17AD8Q37323658-BF6B2C07-1F1D-4D20-B4FA-129A7198B7E7Q38007107-B3FD5E9D-B43E-470D-9CD8-382B0F59AE59Q38636627-0936873A-8898-441A-B952-FB9F60310E00Q39092856-9F4A43BE-0246-490E-92EE-4E3D158994D3Q41820659-39D0394E-10F1-489A-A5F2-137524631D84Q48139316-139107D2-C481-453C-9226-76080728329DQ48665451-A8334103-2DD8-41F5-8050-4C7AECD932B5Q56514116-BAAD8C45-7EBF-41C2-91FE-C9DB5DBDD437Q57729964-714412E6-4AF0-4C24-A0D8-F5ADD1E057F8
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Piracetam: novelty in a unique mode of action.
@ast
Piracetam: novelty in a unique mode of action.
@en
type
label
Piracetam: novelty in a unique mode of action.
@ast
Piracetam: novelty in a unique mode of action.
@en
prefLabel
Piracetam: novelty in a unique mode of action.
@ast
Piracetam: novelty in a unique mode of action.
@en
P2093
P356
P1433
P1476
Piracetam: novelty in a unique mode of action.
@en
P2093
P356
10.1055/S-2007-979230
P478
32 Suppl 1
P577
1999-03-01T00:00:00Z